| Reagan-Udall Foundation

Read more about A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

Read more about Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine

Read more about Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest

The Reagan-Udall Foundation for the FDA, in collaboration with the FDA, hosted a hybrid public workshop on "Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest."

Read more about Throne Biotechnologies Inc

Read more about Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine

Read more about Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

Read more about Immunogenicity and Safety Study of One Booster Dose of Trivalent COVID-19 Vaccine (Vero Cell), Inactivated

Read more about Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine

Read more about Postoperative Sugammadex After COVID-19

Read more about A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination